These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16006165)

  • 1. Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria.
    Wang L; Gamez A; Sarkissian CN; Straub M; Patch MG; Han GW; Striepeke S; Fitzpatrick P; Scriver CR; Stevens RC
    Mol Genet Metab; 2005; 86(1-2):134-40. PubMed ID: 16006165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria.
    Gámez A; Sarkissian CN; Wang L; Kim W; Straub M; Patch MG; Chen L; Striepeke S; Fitzpatrick P; Lemontt JF; O'Neill C; Scriver CR; Stevens RC
    Mol Ther; 2005 Jun; 11(6):986-9. PubMed ID: 15922970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?
    Sarkissian CN; Gámez A
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria.
    Gámez A; Wang L; Sarkissian CN; Wendt D; Fitzpatrick P; Lemontt JF; Scriver CR; Stevens RC
    Mol Genet Metab; 2007 Aug; 91(4):325-34. PubMed ID: 17560821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria.
    Bell SM; Wendt DJ; Zhang Y; Taylor TW; Long S; Tsuruda L; Zhao B; Laipis P; Fitzpatrick PA
    PLoS One; 2017; 12(3):e0173269. PubMed ID: 28282402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report.
    Safos S; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(6):681-92. PubMed ID: 8556141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylalanine ammonia-lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria.
    Ikeda K; Schiltz E; Fujii T; Takahashi M; Mitsui K; Kodera Y; Matsushima A; Inada Y; Schulz GE; Nishimura H
    Amino Acids; 2005 Nov; 29(3):283-7. PubMed ID: 15977040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of phenylalanine ammonia lyase: multiple helix dipoles implicated in catalysis.
    Calabrese JC; Jordan DB; Boodhoo A; Sariaslani S; Vannelli T
    Biochemistry; 2004 Sep; 43(36):11403-16. PubMed ID: 15350127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modern view of phenylalanine ammonia lyase.
    MacDonald MJ; D'Cunha GB
    Biochem Cell Biol; 2007 Jun; 85(3):273-82. PubMed ID: 17612622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of high phenylalanine ammonia lyase activities in roots of Japanese Striped corn: a potential oral therapeutic to treat phenylketonuria.
    López-Villalobos A; Lücker J; López-Quiróz AA; Yeung EC; Palma K; Kermode AR
    Cryobiology; 2014 Jun; 68(3):436-45. PubMed ID: 24657198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pah(enu2) mice.
    Rossi L; Pierigè F; Carducci C; Gabucci C; Pascucci T; Canonico B; Bell SM; Fitzpatrick PA; Leuzzi V; Magnani M
    J Control Release; 2014 Nov; 194():37-44. PubMed ID: 25151978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
    Ambrus CM; Sharma SD; Horváth C; Kalghatgi K; Anthone S; Ambrus JL; Cooley C; Mirand EA
    J Pharmacol Exp Ther; 1983 Mar; 224(3):598-602. PubMed ID: 6681841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria.
    Levy HL; Sarkissian CN; Scriver CR
    Mol Genet Metab; 2018 Aug; 124(4):223-229. PubMed ID: 29941359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.
    Burton BK; Longo N; Vockley J; Grange DK; Harding CO; Decker C; Li M; Lau K; Rosen O; Larimore K; Thomas J;
    Mol Genet Metab; 2020 Aug; 130(4):239-246. PubMed ID: 32593547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential tyrosine-containing loop conformation and the role of the C-terminal multi-helix region in eukaryotic phenylalanine ammonia-lyases.
    Pilbák S; Tomin A; Rétey J; Poppe L
    FEBS J; 2006 Mar; 273(5):1004-19. PubMed ID: 16478474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase.
    Sarkissian CN; Shao Z; Blain F; Peevers R; Su H; Heft R; Chang TM; Scriver CR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2339-44. PubMed ID: 10051643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria.
    Sarkissian CN; Gámez A; Wang L; Charbonneau M; Fitzpatrick P; Lemontt JF; Zhao B; Vellard M; Bell SM; Henschell C; Lambert A; Tsuruda L; Stevens RC; Scriver CR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20894-9. PubMed ID: 19095795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study.
    Longo N; Zori R; Wasserstein MP; Vockley J; Burton BK; Decker C; Li M; Lau K; Jiang J; Larimore K; Thomas JA
    Orphanet J Rare Dis; 2018 Jul; 13(1):108. PubMed ID: 29973227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
    Thomas J; Levy H; Amato S; Vockley J; Zori R; Dimmock D; Harding CO; Bilder DA; Weng HH; Olbertz J; Merilainen M; Jiang J; Larimore K; Gupta S; Gu Z; Northrup H;
    Mol Genet Metab; 2018 May; 124(1):27-38. PubMed ID: 29653686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylketonuria. The in vivo hydroxylation rate of phenylalanine into tyrosine is decreased.
    van Spronsen FJ; Reijngoud DJ; Smit GP; Nagel GT; Stellaard F; Berger R; Heymans HS
    J Clin Invest; 1998 Jun; 101(12):2875-80. PubMed ID: 9637722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.